您的位置: 首页 > 农业专利 > 详情页

The Modified Release Formulation of naproxen sodium
专利权人:
BAYER HEALTHCARE LLC
发明人:
PAUL ROSAR,RACHAN SIRIHORACHAI
申请号:
BR112018007133
公开号:
BR112018007133A2
申请日:
2015.10.09
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
The present invention is the preparation of naproxen, and the release profiles having, which provide, to be equivalent to the pain relief immediately for taking 440 mg (or 2 220 mg) naproxen sodium and also extend pain relief up to 24 hours.Specifically, the present invention is single solid dosage, a combination thereof unique proportions release immediately naproxen sodium product and delay to discharge naproxen sodium layer.More specifically, the present invention is single bilayer tablet, releases immediately 300 320 mg naproxen sodiums, then gradually discharges 450 480 mg naproxen sodiums.When being given as single bilayer tablet, which is capable of providing pain relief in 24 hours.Single bilayer tablet offer releases immediately (IR) naproxen sodium from one layer for initial pain relief, then continuously discharges remaining naproxen sodium from another layer to maintain to extend pain relief up to 24 hours.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充